Validation of recurrence prediction using circulating tumor DNA in patients with curatively treated early stage non-small cell lung cancer | NeoGenomics Laboratories

Publication date

Fri, 06/02/2023 - 12:00

Category

Year

Subtitle

ASCO 2023

File

ASCO_2023_Validation_of_recurrence_prediction_using_ctDNA_in_patients_with_curatively_treated_early-stage_NSCLC.pdf (5.68 MB)

Division